IGC Pharma (IGC) Current Assets (2011 - 2026)
IGC Pharma (IGC) posted quarterly Current Assets of $1.1 million for Q1 2026, down 60.39% year-over-year from $2.9 million in Q1 2025, and down 35.92% quarter-over-quarter from $1.8 million in Q4 2025.
IGC Pharma (IGC) Current Assets (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Current Assets for 16 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 60.39% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 60.39% YoY), while the FY2026 annual figure was $1.1 million, down 60.39% from the prior year.
- Current Assets slipped to $1.1 million in Q1 2026 per IGC's latest filing, from $1.8 million in the prior quarter.
- Across five years, Current Assets topped out at $15.1 million in Q1 2022 and bottomed at $1.1 million in Q1 2026.
- Historically, Current Assets has averaged $5.6 million across 5 years, with a median of $4.2 million in 2024.
- Annual changes were most pronounced in 2023 — Current Assets tumbled 61.7% — and 2024, when it declined 13.21%.
- IGC Pharma's Current Assets stood at $9.4 million in 2022, then sank by 61.7% to $3.6 million in 2023, then decreased by 14.85% to $3.1 million in 2024, then slumped by 41.33% to $1.8 million in 2025, then tumbled by 35.92% to $1.1 million in 2026.
- Business Quant data shows IGC's Current Assets at $1.1 million in Q1 2026, $1.8 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 1.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.15 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | 4.25 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 3.71 Mn |
| Dec 31, 2023 | 3.58 Mn |
| Sep 30, 2023 | 6.12 Mn |
| Jun 30, 2023 | 5.08 Mn |
| Mar 31, 2023 | 6.47 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 11.20 Mn |
| Jun 30, 2022 | 12.73 Mn |
| Mar 31, 2022 | 15.11 Mn |
| Dec 31, 2021 | 19.24 Mn |
| Sep 30, 2021 | 21.70 Mn |
| Jun 30, 2021 | 22.19 Mn |